文献速递心境障碍焦虑、强迫与应激相关障碍

他汀类药物使用与COVID-19期间负性情感偏向的关联:一项英国观察性纵向研究

Associations Between Statin Use and Negative Affective Bias During COVID-19: An Observational, Longitudinal UK Study Investigating Depression Vulnerability.
PubMed 文献 · Biol Psychiatry · 2022-03-19

本研究在2020年4月至2021年2月期间对2043名英国成年人进行观察性在线研究,比较单用他汀类(n=81)、单用降压药(n=126)、两药合用(n=111)及均未使用(n=1725)四组在情感偏向、奖赏加工等认知任务上的表现。结果显示,他汀类使用与愤怒和恐惧面孔识别减少、将此类表情误判为积极表情增加、与损失相关刺激的学习减少相关,且未发现工作记忆受损的证据;基线愤怒面孔识别增加可预测10个月后抑郁和焦虑水平升高。

要点

  • 他汀类使用与愤怒和恐惧面孔识别减少及误判为积极表情增加相关。
  • 他汀类使用与损失相关刺激学习减少相关,单用降压药者未见此表现。
  • 基线愤怒面孔识别增加可预测10个月后抑郁和焦虑水平升高。

核心结论

  • 他汀类使用与提示抑郁心理易感性降低的认知标记相关,支持其作为抑郁预防性治疗的潜在用途。

研究设计与样本

  • 2020年4月至2021年2月在英国开展的观察性在线研究,纳入2043名成年人,比较单用他汀类(n=81)、单用降压药(n=126)、两药合用(n=111)及均未使用(n=1725)四组,使用混合协方差分析和回归模型。

主要发现

  • 他汀类使用与愤怒面孔识别减少相关(F1=9.19,p=.002),与恐惧面孔识别减少相关(F1=6.9,p=.009)。
  • 他汀类使用与将愤怒和恐惧表情误判为积极表情增加相关。
  • 他汀类使用与损失相关刺激学习减少相关(F1,1418=9.90,p=.002)。
  • 基线愤怒面孔识别增加预测10个月后抑郁水平升高(β=3.61,p=.027)和焦虑水平升高(β=2.37,p=.002)。
  • 未发现他汀类使用与工作记忆受损相关的证据。

关键数值与推荐

  • 单用他汀类组n=81,单用降压药组n=126,两药合用组n=111,均未使用组n=1725。
  • 愤怒面孔识别:F1=9.19,p=.002;恐惧面孔识别:F1=6.9,p=.009。
  • 损失相关刺激学习:F1,1418=9.90,p=.002。
  • 基线愤怒面孔识别预测10个月后抑郁:β=3.61,p=.027;预测焦虑:β=2.37,p=.002。

临床怎么用

  • 他汀类使用与提示抑郁心理易感性降低的认知标记相关,支持其作为抑郁预防性治疗的潜在用途。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is growing interest in the antidepressant potential of statins. We tested whether statin use is associated with cognitive markers previously found to indicate psychological vulnerability to depression within the context of the COVID-19 pandemic. METHODS: Between April 2020 and February 2021, we conducted an observational online study of 2043 adults in the United Kingdom. Participants completed cognitive tasks assessing processes related to depression vulnerability, including affective bias and reward processing. We also measured working memory, medication use, and current psychiatric symptoms. Using mixed analysis of covariance and regression models, we compared participants on statins alone (n = 81), antihypertensive medication alone (n = 126), both medications (n = 111), and on neither medication (n = 1725). RESULTS: Statin use was associated with reduced recognition of angry and fearful faces (F1 = 9.19, p = .002; F1 = 6.9, p = .009) and with increased misclassification of these expressions as positive. Increased recognition of angry faces at baseline predicted increased levels of depression and anxiety 10 months later (β = 3.61, p = .027; β = 2.37, p = .002). Statin use was also associated with reduced learning about stimuli associated with loss (F1,1418 = 9.90, p = .002). These indicators of reduced negative bias were not seen in participants taking antihypertensive medication alone, suggesting that they were related to statin use in particular rather than nonspecific demographic factors. In addition, we found no evidence of an association between statin use and impairment in working memory. CONCLUSIONS: Statin use was associated with cognitive markers indicative of reduced psychological vulnerability to depression, supporting their potential use as a prophylactic treatment for depression.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Gillespie AL, Wigg C, Van Assche I, et al. Associations Between Statin Use and Negative Affective Bias During COVID-19: An Observational, Longitudinal UK Study Investigating Depression Vulnerability. Biol Psychiatry. 2022. PMID: 35606186. doi:10.1016/j.biopsych.2022.03.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。